At 12.6% CAGR, the South & Central America Medical Scheduling Software Market is Projected to be Worth US$ 53.40 million by 2028, says The Business Market Insights

According to the Business Market Insights’ research, the South & Central America medical scheduling software market was valued at US$ 26.27 million in 2022 and is expected to reach US$ 53.40 million by 2028, registering a CAGR of 12.6% from 2022 to 2028. Rising adoption of patient-centric approach by healthcare providers and surge in use of smart devices for monitoring health are the critical factors attributed to the South & Central America medical scheduling software market expansion.     

Advancements in mobile technology, coupled with growing health concerns, are fueling the growth of mHealth services (MHS) across the world. Mobile and wireless technologies hold the potential to change the way healthcare is delivered. Rapid advancements in mobile technologies and applications, an increase in new opportunities for integrating mobile health into existing eHealth services, and ongoing expansion of mobile cellular network coverage are among the major factors supporting the proliferation of mHealth solutions. The proliferation of wireless communication would not only help enhance the quality of care and the health of patients but also save huge unnecessary healthcare costs every year by simply assisting in addressing the issue of poor prescription drugs. The applications of mHealth are likely to expand in the coming years. the potential of mHealth apps to help in diabetes care and prevention will be one of the most important domains for mHealth app producers. This helps patients in cutting down additional costs incurred in the form of hospital stays. Also, in addition to the improved internet connectivity, decreasing internet costs, particularly in developing countries, are the major factors boosting the adoption of mHealth applications.

On the contrary, security and privacy issues hurdles the growth of South & Central America medical scheduling software market.  

Based on software, the South & Central America medical scheduling software market is segmented into web-based software and installed software. The web-based software segment held 61.9% share of South & Central America medical scheduling software market in 2022, amassing US$ 16.26 million. It is projected to garner US$ 33.62 million by 2028 to expand at 12.9% CAGR during 2022–2028.

Based on end users, the South & Central America medical scheduling software market is segmented into hospitals, clinics, and other end users. The hospitals segment held 45.0% share of South & Central America medical scheduling software market in 2022, amassing US$ 11.82 million. It is projected to garner US$ 23.81 million by 2028 to expand at 12.4% CAGR during 2022–2028.  

Based on country, the South & Central America medical scheduling software market has been categorized into Brazil, Argentina, and the Rest of South & Central America.  Our regional analysis states that Brazil captured 61.7% share of South & Central America medical scheduling software market in 2022. It was assessed at US$ 16.21 million in 2022 and is likely to hit US$ 33.53 million by 2028, exhibiting a CAGR of 12.9% during 2022–2028. 

Key players operating in the South & Central America medical scheduling software market are AdvancedMD, Inc., Gunei Investment SpA, Q-nomy Inc, and TerminApp GmbH, among others.   

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com